P. Cinque

P. Cinque, E. Sala, P. Ferrante, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Investigation on the role of cell transcriptional factor Sp1 and HIV‐1 TAT protein in PML onset or development

A. Giordano, A. Antinori, P. Cinque, 2005, Journal of cellular physiology.

Zidovudine and frequency of HIV-induced diffuse leukoencephalopathy

A. Lazzarin, P. Cinque, A. Castagna, 1991, The Lancet.

Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2012, AIDS research and treatment.

Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.

P. Cinque, S. Casari, D. Bertelli, 1998, The New England journal of medicine.

Long‐term treatment with zidovudine in patients with human immunodeficiency virus (HIV)‐associated thrombocytopenia: Modes of response and correlation with markers of HIV replication

A. Lazzarin, P. Cinque, E. Santagostino, 1993, European journal of haematology.

Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy

C. Yiannoutsos, A. Lazzarin, B. Musick, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy

P. Cinque, E. Maccagnano, A. Salmaggi, 2001, Neurological Sciences.

Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy

A. Lazzarin, P. Cinque, M. Terreni, 1999, Journal of Neurology.

The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series

A. d’Arminio Monforte, A. Winston, A. Antinori, 2021 .

Relapse of Symptomatic Cerebrospinal Fluid HIV Escape

A. Lazzarin, P. Cinque, S. Gerevini, 2020, Current HIV/AIDS Reports.

Cerebrospinal Fluid HIV-1 Infection Usually Responds Well to Antiretroviral Treatment

R. Price, L. Hagberg, A. Antinori, 2005, Antiviral therapy.

Diagnostic and prognostic significance of β2-microglobulin during HIV infection

A. Lazzarin, P. Cinque, F. Franzetti, 1990, La Ricerca in Clinica e in Laboratorio.

Diagnosis of Polyomavirus Infection, Replication, and Disease

P. Cinque, H. Hirsch, A. Dumoulin, 2010 .

Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls

A. Lazzarin, A. Zangrillo, P. Cinque, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment

R. Maserati, P. Cinque, P. Ferrante, 2011, Journal of NeuroVirology.

Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

C. Pozzilli, P. Cinque, R. Capra, 2017, Viral immunology.

Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.

A. Lazzarin, W. Lüke, P. Cinque, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an update.

A. Lazzarin, P. Cinque, S. Bossolasco, 2002, Journal of neurovirology.

Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patients.

A. Lazzarin, P. Cinque, S. Bossolasco, 2008, The new microbiologica.

Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance

A. Lazzarin, P. Cinque, S. Bossolasco, 1999, Journal of Neurology Neurosurgery & Psychiatry.

Leishmaniasis Virus-Infected Patients with Visceral Management of Human Immunodeficiency Real-Time PCR Assay for Clinical

A. Lazzarin, P. Cinque, S. Bossolasco, 2003 .

How to use Etravirine in clinical practice ? Report from CROI 2012 in Seattle

C. Katlama, P. Cinque, M. Gisslén, 2012 .

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021

O. Kirk, A. Winston, C. Marzolini, 2022, HIV medicine.

Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis.

G. Gerna, P. Cinque, A. V. van Loon, 1998, Journal of neurovirology.

Diagnosis and Clinical Management of Neurological Disorders Caused by Cytomegalovirus in Aids Patients for the European Union Concerted Action on Virus Meningitis and Encephalitis*

G. Gerna, P. Cinque, A. V. van Loon, 1997 .

Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid.

F. Baldanti, A. Lazzarin, M. Furione, 1995, The Journal of infectious diseases.

Expression of the urokinase plasminogen activator receptor (uPAR) and its ligand (uPA) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases

P. Cinque, N. Sidenius, M. Nebuloni, 2009, Journal of NeuroVirology.

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease

A. Lazzarin, R. Price, L. Hagberg, 2004, Journal of Neuroimmunology.

Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes

M. Rastaldi, P. Cinque, M. Saleem, 2015, Scientific Reports.

Guidelines for the diagnosis and management of neurological complications of HIV infection

A. Chaudhuri, P. Martínez-Martín, P. Portegies, 2004, European journal of neurology.

Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.

A. d’Arminio Monforte, J. Miro, A. Lazzarin, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Disseminated rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy

A. Lazzarin, P. Cinque, G. Balconi, 2011, BMC infectious diseases.

Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.

R. Planas, I. Jelcic, M. Sospedra, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus.

A. Lazzarin, P. Cinque, A. Castagna, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

D. Clifford, B. Brew, A. Nath, 2010, Nature Reviews Neurology.

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

R. Reynolds, P. Cinque, M. Salvetti, 2007, The Journal of experimental medicine.

Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system

P. Cinque, Å. Lundkvist, S. Bossolasco, 2002, Journal of Clinical Virology.

CSF Analysis in the Diagnosis of Viral Encephalitis and Meningitis

P. Cinque, Annika Linde, 2003 .

An international external quality assessment of nucleic acid amplification of herpes simplex virus.

P. Cinque, Wim Quint, H. Niesters, 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction.

A. Lazzarin, P. Cinque, L. Vago, 1997, AIDS.

Management Strategies for Herpesvirus Infections of the CNS

A. Lazzarin, P. Cinque, 2000 .

Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid.

A. Lazzarin, P. Cinque, A. Monforte, 1992, The Journal of infectious diseases.

Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.

A. Winston, R. Price, S. Letendre, 2019, AIDS.

Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy.

P. Cinque, M. Pickhardt, T. Weber, 2000, Journal of neurovirology.

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

A. Lazzarin, P. Cinque, L. Galli, 2015, Journal of the International AIDS Society.

Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study).

A. Lazzarin, P. Cinque, L. Galli, 2019, The Journal of antimicrobial chemotherapy.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.

M. Moroni, A. d’Arminio Monforte, A. Lazzarin, 2011, The new microbiologica.

Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV‐related thrombocytopenia

A. Lazzarin, P. Cinque, U. Tirelli, 1993, AIDS.

Central Nervous System HIV Infection in “Less-Drug Regimen” Antiretroviral Therapy Simplification Strategies

A. Lazzarin, P. Cinque, F. Ferretti, 2014, Seminars in Neurology.

Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance

A. Lazzarin, P. Cinque, S. Bossolasco, 2011, Journal of NeuroVirology.

Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.

R. Price, B. Brew, L. Hagberg, 2007, Handbook of clinical neurology.

Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.

A. Lazzarin, P. Cinque, P. Carrera, 2001, AIDS research and human retroviruses.

Long-term remission of HIV-associated primary CNS lymphoma achieved with highly active antiretroviral therapy alone.

A. Lazzarin, P. Cinque, A. Ferreri, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Coinfection of the central nervous system by cytomegalovirus and herpes simplex virus type 1 or 2 in AIDS patients: autopsy study on 82 cases by immunohistochemistry and polymerase chain reaction

A. Isella, P. Cinque, E. Sala, 1996, Acta Neuropathologica.

Detection of DNA of Lymphotropic Herpesviruses in Plasma of Human Immunodeficiency Virus-Infected Patients: Frequency and Clinical Significance

A. Lazzarin, P. Cinque, S. Bossolasco, 2002, Clinical and Vaccine Immunology.

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement

G. Comi, M. Zaffaroni, P. Cinque, 2020, Multiple sclerosis.

Nested PCR for detection of BK virus and JC virus DNA.

P. Cinque, P. Ljungman, G. Bogdanovic, 1994, Clinical and diagnostic virology.

The application of the polymerase chain reaction of cerebrospinal fluid in the clinical management of AIDS-related CNS disorders.

P. Cinque, S. Bossolasco, B. Giudici, 1998, AIDS patient care and STDs.

Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey.

F. Villarroya, Ò. Miró, P. Cinque, 2011, Mitochondrion.

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

A. Lazzarin, A. Zangrillo, P. Cinque, 2020, Clinical Microbiology and Infection.

The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: Defining a consensus terminology

D. Clifford, P. Cinque, I. Koralnik, 2011, Journal of NeuroVirology.

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

C. Marra, A. Antinori, P. Cinque, 2008, AIDS.

CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.

V. S. Wong, S. Cha, J. Cyster, 2013, Blood.

Real-Time PCR Assay for Clinical Management of Human Immunodeficiency Virus-Infected Patients with Visceral Leishmaniasis

A. Lazzarin, P. Cinque, S. Bossolasco, 2003, Journal of Clinical Microbiology.

Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.

P. Cinque, S. Presi, A. Bestetti, 2000, Journal of neurovirology.

Cerebrospinal fluid HIV‐1 RNA levels: correlation with HIV encephalitis

A. Lazzarin, P. Cinque, S. Bossolasco, 1998, AIDS.

HIV-1 infection and cognitive impairment in the cART era: a review.

P. Reiss, J. Schouten, P. Portegies, 2011, AIDS.

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

K. Blennow, H. Zetterberg, R. Price, 2009, BMC neurology.

Nested PCR for detection of BK virus and JC virus DNA.

P. Cinque, P. Ljungman, G. Bogdanovic, 1994, Clinical and diagnostic virology.

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.

D. Fuchs, F. Hecht, R. Price, 2011, The Journal of infectious diseases.

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, The Journal of antimicrobial chemotherapy.

Elevated cerebrospinal fluid levels of monocyte chemotactic protein‐1 correlate with HIV‐1 encephalitis and local viral replication

V. Torri, A. Lazzarin, A. Mantovani, 1998, AIDS.

Cytomegalovirus infections of the nervous system.

P. Cinque, R. Marenzi, D. Ceresa, 1997, Intervirology.

Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine.

A. Lazzarin, P. Cinque, A. Castagna, 1993, Journal of acquired immune deficiency syndromes.

Diagnosis of cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluid.

A. Lazzarin, P. Cinque, M. Terreni, 1995, Scandinavian journal of infectious diseases. Supplementum.

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, BMC Public Health.

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections

K. Blennow, H. Zetterberg, R. Price, 2013, Journal of Neurology.

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

D. Fuchs, R. Price, B. Brew, 2010, AIDS research and therapy.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

Defining and Evaluating HIV-Related Neurodegenerative Disease and Its Treatment Targets: A Combinatorial Approach to Use of Cerebrospinal Fluid Molecular Biomarkers

R. Price, B. Brew, L. Hagberg, 2007, Journal of Neuroimmune Pharmacology.

JC polyomavirus mutants escape antibody-mediated neutralization

A. Lazzarin, Roland Martin, P. Cinque, 2015, Science Translational Medicine.

A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients

M. Moroni, A. Lazzarin, P. Cinque, 1996, Journal of Neurology.

Inflammation burden score in multidrug resistant HIV-1 infection.

P. Cinque, M. Zazzi, L. Galli, 2023, The Journal of infection.

Erratum: Real-Time PCR Assay for Clinical Management of Human Immunodeficiency Virus-Infected Patients with Visceral Leishmaniasis (Journal of Clinical Microbiology (2003) 41, 11 (5080-5084))

A. Lazzarin, P. Cinque, S. Bossolasco, 2004 .

Serum polymerase chain reaction for cytomegalovirus DNA for monitoring ganciclovir treatment in AIDS patients.

A. Lazzarin, P. Cinque, S. Racca, 1996, Scandinavian journal of infectious diseases.

A Mobile Application for Exercise Intervention in People Living with HIV.

A. Lazzarin, P. Cinque, M. Piacentini, 2019, Medicine and science in sports and exercise.

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy

R. Price, P. Cinque, M. Gisslén, 2015, Current HIV/AIDS Reports.

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

O. Kirk, A. Wensing, A. Winston, 2020, HIV medicine.

Brainstem encephalitis resulting from Epstein-Barr virus mimicking an infiltrating tumor in a child.

A. Bizzi, P. Cinque, L. Angelini, 2000, Pediatric neurology.

ReviewCerebrospinal fluid neopterin : an informative biomarker of central nervous system immune activation in HIV-1 infection

D. Fuchs, R. Price, B. Brew, 2015 .

Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology

S. Gianella, T. Burdo, S. Letendre, 2023, The Journal of infectious diseases.

A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

D. Clifford, R. Zivadinov, B. Brew, 2013, Journal of NeuroVirology.

Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex

I. Elovaara, L. Hagberg, P. Cinque, 2001, Journal of Neuroimmunology.

Susac’s syndrome as HIV-associated immune reconstitution inflammatory syndrome

A. Lazzarin, B. Colombo, P. Cinque, 2013, AIDS Research and Therapy.

2nd International Conference on Progressive Multifocal Leukoencephalopathy (PML) 2015: JCV virology, progressive multifocal leukoencephalopathy pathogenesis, diagnosis and risk stratification, and new approaches to prevention and treatment

Ilse S. Peterson, K. Tyler, E. Major, 2015, Journal of NeuroVirology.

Retrospective Study On The Outcomes Of Two-drugs Regimens Based On Dolutegravir Plus One Reverse Transcriptase Inhibitor In Virologically Suppressed, HIV-Infected Patients.

A. Lazzarin, P. Cinque, L. Galli, 2020, International journal of antimicrobial agents.

Acquisition of human immunodeficiency virus infection in a patient with multiple sclerosis: could these conditions positively influence each other’s course?

P. Cinque, D. Franciotta, M. Ferrò, 2020, Journal of NeuroVirology.

Failure to detect JC virus DNA in cerebrospinal fluid of multiple sclerosis patients.

R. Bergamaschi, P. Cinque, G. Piccolo, 2006, Multiple Sclerosis.

Sismes IX National Congress

P. Cinque, G. Merati, G. Pavei, 2017, Sport Sciences for Health.

Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.

M. Peluso, D. Fuchs, H. Zetterberg, 2013, The Journal of infectious diseases.

CSF neurofilament protein (NFL) — a marker of active HIV-related neurodegeneration

R. Price, B. Brew, L. Hagberg, 2007, Journal of Neurology.

Changing incidence of central nervous system diseases in the EuroSIDA cohort

A. Mocroft, O. Kirk, F. Antunes, 2004, Annals of neurology.

Cognitive Health in Persons With Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging

A. Winston, S. Letendre, P. Cinque, 2023, The Journal of infectious diseases.

Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA

A. Winston, R. Swanstrom, R. Price, 2016, Journal of virus eradication.

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

M. Peluso, D. Fuchs, R. Price, 2012, AIDS.

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, BMC Medicine.

The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS.

A. Lazzarin, P. Cinque, E. Fainardi, 2002, Journal of medical microbiology.

Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

C. Marra, C. Hall, N. Sacktor, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

P. Cinque, P. McKay, L. Piemonti, 2021, medRxiv.

Symptomatic cerebrospinal fluid escape.

P. Cinque, S. Gerevini, F. Turrini, 2019, AIDS.

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA)

A. Antinori, P. Cinque, P. Lorenzini, 2011, Journal of NeuroVirology.

Biomarkers of HIV-1 CNS infection and injury

J T Becker, J. Becker, R. Price, 2007, Neurology.

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients

D. Fuchs, A. Lazzarin, H. Zetterberg, 2016, Medicine.

Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.

R. Price, B. Brew, L. Hagberg, 2007, The Journal of infectious diseases.

Multiple viral infections in HIV-infected children with chronically-evolving hepatitis.

P. Cinque, P. Falconieri, A. Krzysztofiak, 1993, Archives of virology. Supplementum.

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.

A. d’Arminio Monforte, R. Bruno, A. Lazzarin, 2015, The new microbiologica.

Pharmacokinetics of Zidovudine in HIV‐Positive Patients with Liver Disease

A. Lazzarin, P. Cinque, A. Nicolin, 1994, Journal of clinical pharmacology.

Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes

P. Cinque, M. Bonato, A. Mastrangelo, 2021, Neuroscience Letters.

Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab‐treated multiple sclerosis patients

V. Martinelli, G. Comi, R. Gold, 2019, Annals of neurology.

Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis

P. Cinque, A. Prelle, D. Franciotta, 2012, Journal of Neurovirology.

Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2.

A. Lazzarin, P. Cinque, S. Bossolasco, 2007, AIDS.

Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum.

R. Price, P. Cinque, P. Perucca, 2009, Acta neurologica Belgica.

Cerebrospinal fluid markers in the management of central nervous system HIV infection and the AIDS dementia complex.

R. Price, B. Brew, L. Hagberg, 2009 .

Cognitive impairment in people living with HIV: consensus recommendations for a new approach

B. Ances, A. Winston, N. Nakasujja, 2023, Nature Reviews Neurology.

Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape

R. Price, P. Cinque, M. Gisslén, 2023, Journal of Neuroimmunology.

A. Mocroft, A. d’Arminio Monforte, J. Lundgren, 2004 .

Cerebrospinal fluid interferon-γ-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection

R. Price, L. Hagberg, P. Cinque, 2005, Journal of Neuroimmunology.

No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)

D. Fuchs, H. Zetterberg, R. Price, 2017, Virulence.

Progressive Multifocal Leukoencephalopathy in a Child with Hyperimmunoglobulin E Recurrent Infection Syndrome and Review of the Literature

P. Cinque, L. Angelini, L. Vago, 2001, Neuropediatrics.

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

P. Cinque, P. McKay, L. Piemonti, 2022, Journal of Clinical Immunology.

No support for premature CNS aging in HIV when measured by cerebrospinal fluid hyperphosphorylated tau (p-tau)

D. Fuchs, H. Zetterberg, R. Price, 2017 .

CSF HIV-RNA load across the spectrum of untreated HIV-1 infection: a cross-sectional multi-center study

A. Winston, B. Brew, A. Antinori, 2022 .

Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201thallium single photon emission tomography.

F. Fazio, C. Messa, A. Lazzarin, 1997, AIDS.

HIV-DNA undetectability during chronic HIV infection: frequency and predictive factors.

P. Cinque, L. Galli, A. Castagna, 2020, The Journal of antimicrobial chemotherapy.

Spatial working memory in asymptomatic HIV-infected subjects.

P. Cinque, S. Scarone, A. Campana, 1999, The Journal of neuropsychiatry and clinical neurosciences.

Benefits of a 12 week physical activity programme on muscle and bone health in people living with HIV

A. Lazzarin, P. Cinque, G. Banfi, 2021, Journal of cachexia, sarcopenia and muscle.

Diagnosis of Virus‐associated Opportunistic Diseases of the Central Nervous System in Patients with HIV Infection by Polymerase Chain Reaction on Cerebrospinal Fluid

A. d’Arminio Monforte, A. Lazzarin, P. Cinque, 1994, Annals of the New York Academy of Sciences.

Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.

R. Price, L. Hagberg, P. Cinque, 2005, Journal of neuroimmunology.

Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.

P. Cinque, S. Presi, P. Morelli, 2000, Journal of neurovirology.

First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, A. Lazzarin, 2018, HIV medicine.

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0

S. McCormack, A. Mocroft, O. Kirk, 2018, HIV medicine.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study).

P. Cinque, L. Galli, P. Burbelo, 2021, The Journal of antimicrobial chemotherapy.

Cerebrospinal fluid HIV RNA escape symptomatology.

A. Winston, A. Antinori, P. Cinque, 2021, AIDS.

Comparison of Three Nucleic Acid Amplification Assays of Cerebrospinal Fluid for Diagnosis of Cytomegalovirus Encephalitis

A. Lazzarin, P. Cinque, M. Terreni, 2001, Journal of Clinical Microbiology.

Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation

P. Cinque, A. Tomelleri, C. Campochiaro, 2023, European Journal of Clinical Microbiology & Infectious Diseases.

Age-dependent neurologic manifestations of HIV infection in childhood

P. Cinque, F. Triulzi, A. Plebani, 2000, Neurological Sciences.

Epstein-Barr virus DNA in the cerebrospinal fluid of an HIV patient with primary cerebral lymphoma

P. Cinque, F. Triulzi, A. Plebani, 1998, European Journal of Pediatrics.

Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.

A. Lazzarin, P. Cinque, S. Bossolasco, 2008, The American journal of tropical medicine and hygiene.

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, M. Capobianchi, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.